ArriVent BioPharma AVBP
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$7.58M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 37.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 16.69% to 11.76% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Vivo Capital, LLC | VC/PE Fund | 2026/Q3 | +943,575 | 5.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +236,380 | 3.9% |
| FMR | Mutual Fund | 2026/Q3 | +188,090 | 5.7% |
| E Fund Management Co., Ltd. | Mutual Fund | 2026/Q3 | +168,476 | 0.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +156,923 | 6.6% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +113,489 | 0.6% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +102,927 | 1.1% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +82,592 | 2.0% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +75,135 | 0.1% |
| Vivo Capital, LLC | VC/PE Fund | 2026/Q3 | +796,181 | 3.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +720,095 | 6.6% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +650,000 | 1.9% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +503,216 | 1.7% |
| Foresite Capital Management, LLC | VC/PE Fund | 2026/Q3 | +301,341 | 0.6% |
| Infinitum Asset Management, LLC | Hedge Fund | 2026/Q3 | +289,461 | 8.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | Robin LaChapelle | Co-Founder & COO | Derivative Exercise and Retained | +40,693 | $6.24 | 570,906 |
| 17 Jun 2026 | Kristine Peterson | Lead Independent Director | Other Derivative Acquisition | +13,562 | $31.74 | 13,562 |
| 17 Jun 2026 | Merdad Parsey | Independent Director | Other Derivative Acquisition | +13,562 | $31.74 | 13,562 |
| 17 Jun 2026 | John Hohneker | Independent Director | Other Derivative Acquisition | +13,562 | $31.74 | 13,562 |
| 17 Jun 2026 | Christian Nolet | Independent Director | Other Derivative Acquisition | +13,562 | $31.74 | 13,562 |
| 1 Feb 2026 | Zhengbin Yao | Chairperson & CEO | Other Derivative Acquisition | +550,000 | $22.67 | 550,000 |
| 1 Feb 2026 | Robin LaChapelle | Co-Founder & COO | Other Derivative Acquisition | +130,000 | $22.67 | 130,000 |
| 1 Feb 2026 | Stuart Lutzker | Co-Founder, President of Research & Development and Director | Other Derivative Acquisition | +150,000 | $22.67 | 150,000 |
| 1 Feb 2026 | Winston Kung | Chief Financial Officer | Other Derivative Acquisition | +140,000 | $22.67 | 140,000 |
| 1 Feb 2026 | James Kastenmayer | General Counsel | Other Derivative Acquisition | +130,000 | $22.67 | 130,000 |
| 9 Dec 2025 | Hillhouse Capital Management, Ltd. | Open Market Disposition | -555,555 | $23.37 | 3,741,271 | |
| 10 Jul 2025 | Robin LaChapelle | Co-Founder & COO | Derivative Exercise and Retained | +11,153 | $2.28 | 530,213 |
| 17 Jun 2025 | Kristine Peterson | Lead Independent Director | Other Derivative Acquisition | +15,502 | $24.89 | 15,502 |
| 17 Jun 2025 | Merdad Parsey | Independent Director | Other Derivative Acquisition | +15,502 | $24.89 | 15,502 |
| 17 Jun 2025 | John Hohneker | Independent Director | Other Derivative Acquisition | +15,502 | $24.89 | 15,502 |
| 17 Jun 2025 | Christian Nolet | Independent Director | Other Derivative Acquisition | +15,502 | $24.89 | 15,502 |
| 27 Apr 2025 | Merdad Parsey | Independent Director | Other Derivative Acquisition | +28,346 | $20.92 | 28,346 |
| 2 Feb 2025 | Zhengbin Yao | Chairperson & CEO | Other Derivative Acquisition | +380,000 | $27.56 | 380,000 |
| 2 Feb 2025 | Robin LaChapelle | Co-Founder & COO | Other Derivative Acquisition | +120,000 | $27.56 | 120,000 |
| 2 Feb 2025 | Stuart Lutzker | Co-Founder, President of Research & Development and Director | Other Derivative Acquisition | +120,000 | $27.56 | 120,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 5,797,018 | 11.8% | 3.4 |
| 15 Oct 2026 | 6,806,605 | 13.8% | 2.2 |
| 30 Sep 2026 | 8,451,472 | 17.1% | 11.3 |
| 15 Sep 2026 | 8,766,246 | 17.8% | 17.7 |
| 31 Aug 2026 | 8,691,715 | 17.6% | 20.4 |
| 14 Aug 2026 | 8,227,393 | 16.7% | 21.8 |
No comments yet — be the first to weigh in on AVBP.
Sign in to join the discussion.